(1)

Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation.

(2)

In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of the preparation set out in the Annex. That application was accompanied by the particulars and documents required under Article 7(3) of that Regulation.

(3)

The application concerns a new use of the preparation of endo-1,4-beta xylanase EC 3.2.1.8 produced by Bacillus subtilis (LMG S-15136), as a feed additive for ducks, to be classified in the additive category ‘zootechnical additives’.

(4)

The method of analysis included in the application for authorisation in accordance with Article 7(3)(c) of Regulation (EC) No 1831/2003 concerns the determination of the active substance of the feed additive in feed. The method of analysis referred to in the Annex to this Regulation is therefore not to be understood as a Community method of analysis within the meaning of Article 11 of Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (2).

(5)

The use of endo-1,4-beta xylanase EC 3.2.1.8 produced by Bacillus subtilis (LMG S-15136) was authorised without a time limit for piglets (weaned) by Commission Regulation (EC) No 1206/2005 (3) and for chickens for fattening by Commission Regulation (EC) No 1259/2004 (4). New data were submitted in support of an application for authorisation for ducks. The European Food Safety Authority (the Authority) concluded in its opinion of 15 June 2006 (5) that the safety of this additive for the consumer, the user and the environment have already been established and will not be changed by the proposed new use. It further concluded, that the use of the preparation does not have an adverse effect on this additional animal category and that the use of that preparation can improve the zootechnical parameters in ducks. The Authority does not consider that there is a need for specific requirements of post market monitoring. It also verified the report on the method of analysis of the feed additive in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003.

(6)

The assessment of that preparation shows that the conditions for authorisation, provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that preparation should be authorised, as specified in the Annex to this Regulation.

(7)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(1)

Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation.

(2)

In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of the preparation set out in the Annex. That application was accompanied by the particulars and documents required under Article 7(3) of that Regulation.

(3)

The application concerns authorisation of the enzyme preparation 3-phytase produced by Aspergillus niger (CBS 101.672) for weaned piglets, pigs for fattening, and chickens for fattening to be classified in the additive category ‘zootechnical additives’.

(4)

The European Food Safety Authority (the Authority) concluded in its opinions of 15 June 2006 and of 17 May 2006 that 3-phytase produced by Aspergillus niger (CBS 101.672) does not have an adverse effect on animal health, human health or the environment (2). It further concluded that the enzyme preparation 3-phytase produced by Aspergillus niger (CBS 101.672) does not present any other risk which would, in accordance with Article 5(2) of Regulation (EC) No 1831/2003, exclude authorisation. The opinion of the Authority recommends appropriate measures for user safety. It does not consider that there is a need for specific requirements of post market monitoring. This opinion also verifies the report on the method of analysis of the feed additive in feed submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003. The assessment of that preparation shows that the conditions for authorisation, provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that preparation should be authorised, as specified in the Annex to this Regulation.

(5)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(1)

Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such authorisation.

(2)

An application for authorisation has been submitted for L-histidine monohydrochloride monohydrate as an amino acid.

(3)

As the application for authorisation was submitted before the date of application of Regulation (EC) No 1831/2003, it was submitted under Council Directive 82/471/EEC of 30 June 1982 concerning certain products used in animal nutrition (2). As from 18 October 2004, amino acids, their salts and analogues fall under the scope of Regulation (EC) No 1831/2003. The application is therefore to be considered as an application under Article 7 of Regulation (EC) No 1831/2003.

(4)

In order to comply with the requirements laid down in Article 7 of Regulation (EC) No 1831/2003, additional information was submitted in support of the application.

(5)

The application concerns authorisation of L-histidine monohydrochloride monohydrate as a feed additive for salmonids, to be classified in the additive category ‘nutritional additives’ and the functional group ‘amino acids, their salts and analogues’.

(6)

The European Food Safety Authority (the Authority) concluded in its opinions of 2 March 2005 (3) and of 18 October 2006 (4) that L-histidine monohydrochloride monohydrate does not have an adverse effect on animal health, human health or the environment. It further concluded that L-histidine monohydrochloride monohydrate does not present any other risk which would, in accordance with Article 5(2) of Regulation (EC) No 1831/2003, exclude authorisation. According to that opinion, it is an essential amino acid also for fish, and the use of that preparation has been shown to prevent cataracts under farming conditions for salmonids. The opinion of the Authority recommends appropriate measures for user safety. It does not consider that there is a need for specific requirements of post market monitoring. The report on the method of analysis of the feed additive in feed was submitted by the Community Reference Laboratory set up by Regulation (EC) No 1831/2003 to the Authority. The assessment of that preparation shows that the conditions for authorisation, provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of that preparation should be authorised, as specified in the Annex to this Regulation.

(7)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(1)

Regulation (EC) No 998/2003 lays down the animal health requirements applicable to the non-commercial movement of pet animals and the rules applicable to checks on such movements.

(2)

Regulation (EC) No 998/2003 lays down that a list of third countries from which the movement of pet animals to the Community may be authorised, provided that certain requirements are met, is to be set out in Part C of Annex II to that Regulation.

(3)

The list in Part C of Annex II to Regulation (EC) No 998/2003 includes third countries and territories which are free of rabies and third countries and territories in respect of which the risk of rabies entering the Community as a result of movements from those third countries and territories has been found to be no higher than the risk associated with movements between Member States.

(4)

From the information submitted by the competent authorities of Malaysia, it appears that the risk of rabies entering the Community as a result of movements of pet animals from that country is no higher than the risk associated with movements of pet animals between Member States or from third countries already listed in Regulation (EC) No 998/2003. Therefore Malaysia should be included in the list set out in Part C of Annex II to Regulation (EC) No 998/2003.

(5)

Since Bulgaria and Romania have been Member States since 1 January 2007, in the interest of clarity of Community legislation it is necessary to remove references to those countries from Part C of Annex II to Regulation (EC) No 998/2003 with effect from the date of accession.

(6)

Regulation (EC) No 998/2003 should therefore be amended accordingly.

(7)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(1)

The following entries are deleted:

‘BG — Bulgaria

RO — Romania’.

(2)

The following entry is inserted: ‘MY — Malaysia’.

(1)

Directive 71/316/EEC makes provision, in item 3.1.1.1(a) of Annex II, for the distinguishing capital letters of Member States to be used for the EEC initial verification mark affixed on a measuring instrument and indicating that the latter conforms to the EEC requirements.

(2)

Directive 71/316/EEC makes provision, in item 3.2.1 of Annex II, for the drawings, showing the shape, dimensions and outline of the letters for the EEC initial verification marks as laid down in item 3.1 of that Annex.

(3)

The drawings of the distinguishing letters were not provided in the Act of Accession of Austria, Finland and Sweden and in the 2003 Act of Accession. According to Annex II, Chapter 1, point D1.b of the Act of Accession of Austria, Finland and Sweden, and of the 2003 Act of Accession, the drawings to which Annex II item 3.2.1 of Directive 71/316/EEC refers are supplemented by the requisite letters.

(4)

It is therefore necessary to amend item 3.2.1 of Annex II to Directive 71/316/EEC in order to include the drawings of the distinguishing letters.

(5)

The measures provided for in this Directive are in accordance with the opinion of the Committee for Adjustment to Technical Progress set up under Article 17 of Directive 71/316/EEC,